Growing up, cancer was as much a part of Jessica Baladad's life as “Space Jam” or monkey bars were for…
Read More »Metastatic
A new form of tumor infiltrating lymphocyte (TIL) therapy, a form of personalized cancer immunotherapy, dramatically improved the treatment's effectiveness…
Read More »Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and…
Read More »Clinically meaningful and statistically significant results from the Phase 3 BREAKWATER trial show objective response rate of 61% with Pfizer…
Read More »Tumor cells circulating in the blood are the “germ cells” of breast cancer metastases. They are very rare and could…
Read More »